$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
广谱抗癌药物拉罗替尼说明书
2025-10-19 11:44:20
Check Details
BRAFV600突变黑色素瘤组合治疗法达拉非尼+迈吉宁
2025-10-19 11:44:20
Check Details
达拉非尼联合曲美替尼治疗黑色素瘤的效果如何?
2025-10-19 11:44:20
Check Details
黑色素瘤药物达拉非尼(泰菲乐)服用方法
2025-10-19 11:44:20
Check Details
黑色素瘤治疗药物达拉非尼去哪可以买到?
2025-10-19 11:44:20
Check Details
BRAFV600突变黑色素瘤一线治疗方案:达拉非尼+曲美替尼
2025-10-19 11:44:20
Check Details
达拉非尼治疗黑色素瘤的安全性如何?
2025-10-19 11:44:20
Check Details
黑色素瘤治疗用药达拉非尼疗效好吗?
2025-10-19 11:44:20
Check Details
黑色素瘤治疗用药达拉非尼去哪可以买到?
2025-10-19 11:44:20
Check Details
迈吉宁曲美替尼服药注意事项
2025-10-19 11:44:20
Check Details
BRAFV600突变黑色素瘤联合治疗法迈吉宁+泰菲乐
2025-10-19 11:44:20
Check Details
迈吉宁(曲美替尼)的用途和价格
2025-10-19 11:44:20
Check Details
1
2
...
6678
6679
6680
6681
6682
6683
6684
...
10233
10234
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Post-Enzalutamide mCRPC: HRR/PARP, PSMA Radioligand, and Chemotherapy Sequencing
2
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
3
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
4
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
5
Bedaquiline for Drug-Resistant TB: 24-Week Regimen, Combination Duration, and When to Stop or Extend
6
Acalabrutinib Dosing and Combination Regimens: CLL/SLL, MCL, Safety Adjustments
7
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
8
Bosutinib for Ph+ CML: Indications, Dosing Adjustments, and Hepatic/Renal Safety
9
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
10
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
11
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
12
AZA+VEN+IVO Triplet Therapy for Newly Diagnosed IDH1 AML: High Response Rates and Durable Efficacy